Search Results 71-80 of 15428 for infliximab

  1. Psoriatic arthritis - Diagnosis & treatment - Mayo Clinic

    The medicines include adalimumab (Humira), certolizumab (Cimzia), etanercept (Enbrel) and golimumab (Simponi). They also include infliximab (Remicade), ...

  2. Adalimumab-ryvk (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-ryvk injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis. It is used in children 2 years ...

  3. Adalimumab-aaty (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-aaty injection is used to treat the symptoms and prevent the progression of moderate to severe rheumatoid arthritis and ankylosing spondylitis. It is ...

  4. Biomarkers of Treatment Response in Rheumatoid Arthritis - Mayo Clinic

    Participation eligibility · TNF inhibitors (adalimumab, certolizumab, etanercept, golimumab, or infliximab) · Abatacept (Orencia; IV or SC) · Tocilizumab (Actemra; ...

  5. Smallpox and mpox vaccine, live (intradermal route, subcutaneous route) - Mayo Clinic

    Infliximab; Ixekizumab; Lebrikizumab-lbkz; Leflunomide; Leniolisib; Lovotibeglogene Autotemcel; Mirikizumab-mrkz; Mycophenolate Mofetil; Mycophenolic Acid ...

  6. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    ... infliximab, adalimumab, or certolizumab pegol) per study criteria; Have screening laboratory test results within protocol-specified parameters. Exclusion ...

  7. Adalimumab-atto (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-atto injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  8. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission - Mayo Clinic

    ... Infliximab 10 mg/kg q4wk > 5mg/ml Adalimumab 40 mg qwk > 7.5mg/ml Certolizumab 400 mg q2wk > 25mg/ml Vedolizumab 300 mg q4wk >15mg/mlUstekinumab 90 mg q4wk ...

  9. Adalimumab-adaz (subcutaneous route) - Mayo Clinic

    Adalimumab-adaz injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  10. Behcet disease - Diagnosis and treatment - Mayo Clinic

    Medicines include infliximab (Remicade) and adalimumab (Humira). Side effects might include headache, skin rash and a higher risk of infections. Request an ...